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In his letter, he suggested that I might like to read the 
papers before our next consultation, as he would like to 
discuss them with me, which for me absolutely exem-
plified the challenge of the time constraints on busy 
doctors and other clinical staff. 
When he came in, I thanked him for his letter and 
the papers, but I stressed to him that I am no expert in 
prostate cancer and that I felt that he really needed to 
discuss the papers with his urologist. I will never forget 
his response. “I know you’re not an expert in prostate 
cancer”, he said. “You’re an expert in me”. And he was 
right, and very wise. He understood the key role of the 
generalist doctor in the world of multimorbidity, and 
this really difficult balance we have to make between the 
ever-increasing levels of detailed scientific knowledge 
that can help our patients, and the need to understand 
and treat the whole person, the whole patient.
I have often thought that focusing on a single condi-
tion is like having a few beautifully clear and focused 
pixels, without having the whole picture. And without 
the whole picture, who knows what we are really look-
ing at and treating?
Multimorbidity is very much the key focus of this 
journal, and the challenges that it brings have been well 
described. In a healthcare system designed around sin-
gle conditions, with hospital departments of cardiology, 
respiratory medicine, gastroenterology, and the rest, 
comorbidities can feel like a nuisance, rather than the 
norm. But as Stewart Mercer and others have shown 
[1], there are more people in the UK with two or more 
long-term conditions than there are with one long-term 
condition. And this is not just a matter of ageing. There 
are more people with two or more comorbidities under 
the age of 65 years than there are over the age of 65 [2]. 
It is not often that a single patient successfully symbol-
izes almost every important trend in modern medicine, 
but one particular man achieved this in a solitary consul-
tation. He was a patient in my general practice. He was 
77 years old – exemplifying the ageing population, and 
had only lived in my area for 3 or 4 years – exemplifying 
an increasingly mobile population. I knew him well and 
saw him often – combining an aspiration for continu-
ity, and increasing consultation rates in primary care. 
He had prostate cancer, but he also had hypertension, 
diabetes, coronary artery disease, macular degenera-
tion, hyperlipidaemia, an arthritic right hip, and, hardly 
surprisingly, depression. This was multimorbidity par 
excellence.
He took 17 tablets a day, which is not unusual these 
days for someone with hypertension and diabetes – 
exemplifying the challenge of polypharmacy, and on 
this particular occasion, he had written to me before 
the consultation enclosing copies of a paper from the 
Lancet and another from the New England Journal of Medi-
cine, both on the topic of the possible management of 
his prostate cancer – which absolutely exemplifies the 
changes brought about by the digital world, increasing 
availability of information for patients, and a major and 
positive change in the doctor–patient relationship.
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So it is unimorbidity that is the outlier, the less usual 
state of affairs, and comorbidity and multimorbidity, 
which are the norm.
The impact is not just on the organization of 
care. Much research excludes patients with comor-
bidities, producing detailed and accurate research on 
potentially highly unusual populations. Guidelines 
too become a challenge. Within the National Insti-
tute for Health and Care Excellence (NICE), as one 
of the world’s foremost producers of guidelines, we 
absolutely recognize that simply producing more and 
more guidelines based on single conditions is not the 
whole answer, and we are working on guidelines on 
the management of multimorbidity to be published in 
the autumn of 2016.
Indeed, unthinking application of single-condition 
guidelines carries a very real risk of triggering over-
treatment and polypharmacy. We know that in England, 
the average elderly person in a care home will be on nine 
different medications [3]. Nine is the average, but for 
many it is even more. The evidence base for the benefits 
of such polypharmacy is poor, and the risk of side effects 
is surely magnified with every drug that is added, some-
times because the prescriber feels that the guidelines tell 
them that they have to do this.
In fact, every piece of NICE guidance carries the 
following extraordinarily important words: “Healthcare 
professionals are expected to take it fully into account when 
exercising their clinical judgement. However, the guidance does 
not override the individual responsibility of healthcare profes-
sionals to make decisions appropriate to the circumstances of the 
individual patient, in consultation with the patient and/
or guardian or carer, and informed by the summaries of product 
characteristics of any drugs”.
These are vitally important words, but raise the ques-
tion as to how many healthcare professionals read them? 
It would be a concern if people treat these like the terms 
and conditions they face when downloading new soft-
ware. The number of doctors who complain to me that 
NICE guidelines do not allow for patient autonomy and 
the complexity of multimorbidity shows that they hurry 
past these important words to get to the “real facts”… 
the dose of the drug, the diagnostic test, etc. Within 
NICE, we are certainly trying to address the human fac-
tors that get in the way of people taking this message 
firmly on board. Understanding this issue really is criti-
cally important.
Indeed, the complexity of multimorbidity flags up 
another major issue. If you have eight different long-term 
conditions (and I well remember a patient with coronary 
artery disease, hypertension, diabetes, hyperlipidaemia, 
chronic kidney disease, macular degeneration, osteo-
arthritis of the hip, and depression) – then, what does 
good care look like? It is unlikely that it will look like a 
simple addition of the guidelines on all eight conditions. 
Indeed, it seems clear that the only person who can say 
what appears to be good for a person with these comor-
bidities is the patient themselves. 
And, in addition, we are absolutely stressing how 
incredibly important it is to work with patients – under-
standing their needs and aspirations, and, to coin a 
phrase, “doing medicine with patients rather than doing 
it to them”. Taking into account the needs and aspira-
tions of the individual patients and their families should 
absolutely move healthcare away from the many aspects 
of frankly ludicrous polypharmacy. The mother of a 
colleague of mine suffers from very severe dementia, 
and has had a recent major stroke, and a fractured hip. 
Whilst in hospital, she was started on a statin. When 
challenged as to the appropriateness of this therapy, the 
prescribing doctor said, “I prescribed it because that’s 
what the guidelines say I should do.” 
What the guidelines said was that the prescriber should 
take into account the circumstances of the individual 
patient. Simply adding therapies because of a misreading 
of the function of guidelines is not good medicine. It is 
thoughtless medicine. And prescribing is an activity that 
justifies considerable thought.
Polypharmacy as a side-effect feature of multimor-
bidity is an issue that is of major importance. There 
is infinitely more research into the benefit of adding 
therapies than there is into the benefit of stopping treat-
ments, but with vast numbers of patients taking multiple 
drug regimens with poor evidence of how the various 
therapies might interact, is an area that needs far greater 
attention.
Indeed, NICE is giving this area a great deal of 
attention. Whilst NICE guidelines on managing mul-
timorbidity will be published in September 2016, there 
has already been work into medicines optimization [4], 
and into the social care of older people with multiple 
long-term conditions [5].
But multimorbidity raises many more challenges than 
guidelines, research, and polypharmacy. The whole 
organization of secondary care medicine over the past 
60 years has been based around single conditions or 
systems – with departments of cardiology, respiratory 
medicine, and such like. As multimorbidity becomes 
the norm, there is an ever-increasing need to train gen-
eralists – a development strongly recommended by the 
Future Hospital Commission in its report for the Royal 
College of Physicians [6].
And yet, consistently and bizarrely, many within 
medicine see generalism as an unattractive career choice. 
In the UK, USA, and in many other countries, the 
smaller a clinician’s area of expertise, the higher his or 
her prestige. The more one thinks about this logically, 
the more counterintuitive it is. Generalists are seen as 
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being a lower form of medicine – unattractive to many 
students, or at best a career phase to be endured en route 
to a specialism. 
In an era of multimorbidity, generalist doctors 
become increasingly important. Without the availability 
of generalists in primary and secondary care, patients 
face having to see multiple specialists, a situation which 
is frequently a recipe for poor communication, poor 
holistic care, wasted patient time, and considerable 
duplication and waste. 
And, of course, the real “expert in me” is not the 
 doctor. It is the patient. Recognizing that will be the real 
revolution.
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